跳至主要内容
临床试验/CTRI/2023/10/058349
CTRI/2023/10/058349招募中Unknown

To Study the Role of Plasma Von Willebrand Factor Antigen (vWF) to A Disintegrin-like and Metalloproteinase With Thrombospondin Type-1 Motifs 13 (ADAMTS-13) Activity Ratio as a Predictor of Development of Extrahepatic Organ Failure in Acute on Chronic Liver Failure (ACLF) Patients. - NI

Institute of Liver and Biliary Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • All the patients with age >18 years who are diagnosed having ACLF fulfilling APASL ACLF criteria and do not have any extrahepatic organ failure at enrollment.

排除标准

  • 1) Patients on antiplatelet or anticoagulant therapy for at any point of time in last 7 days
  • 2) Pregnant female
  • 3) Patient receiving N-acetyl cysteine (NAC) (interferes with the vWF assay)

研究者

相似试验